CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
SBRTradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01949506
NCT01949506N/ACompleted
CompareCT.gov

Pilot Study Evaluating Stereotactic Body Radiation Therapy (SBRT) and Adaptive Radiation Therapy (ART) for Pulmonary Metastases From Soft Tissue Sarcomas

Medical College of Wisconsin·interventional·Posted Sep 24, 2013·Updated Feb 28, 2023

In Brief

A clinical study evaluating SBRT for Stage IV Adult Soft Tissue Sarcoma and Sarcoma,Soft Tissue. Completed, enrolled 9 participants across 1 site.

Detailed Summary

This is a prospective study to document the local control rates with SBRT specifically for pulmonary metastases from soft tissue sarcoma. This study will prospectively document acute and late toxicity, quality of life (QoL), tumor control, and survival.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStage IV Adult Soft Tissue Sarcoma, Sarcoma,Soft Tissue
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 24, 2013
Enrollment StartSep 24, 2013
Primary CompletionOct 4, 2019
TodayJul 2, 2026
Enrollment to primary: 6.0 yearsPosted 12.8 years ago

Interventions

SBRTradiation

Stereotactic Body Radiation Therapy